22 hrs ago
Covance Given Average Rating of "Hold" by Analysts
Covance has earned a consensus rating of "Hold" from the fifteen brokerages that are presently covering the stock, Analyst RN reports .
Jefferies Group Increases Covance Price Target to $117.00
The firm currently has a "buy" rating on the stock. Jefferies Group's target price indicates a potential upside of 14.89% from the company's current price.
Covance Inc. Invites You To Join The Webcast Of Its First Quarter...
Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com .
Covance Inc. Expands Global Biologics Capabilities
March 25, 2014 - Covance Inc. , one of the world's largest and most comprehensive drug development services companies, today announced that it is building on its expertise in biologics development with new investments to meet growing client demand, including the expansion of its global bioanalytical footprint and the addition of scientific leaders ... (more)
Covance Sets New 12-Month High at $105.08
Shares of Covance hit a new 52-week high during trading on Thursday , AR Network reports.